Legend Biotech Corp
LEGN
NASDAQ
Biotechnology
$20.37
USD
+0.10 (+0.49%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.93B
Volume 2.0M
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q4 2022 | Q4 2023 | Q4 2024 | Q4 2025 |
|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | — |
YoY Growth | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | — |
Gross Profit | 0.0 | 0.0 | 0.0 | — |
Selling, General & Administrative | 0.0 | 0.0 | 0.0 | — |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | — |
Total Operating Expenses | 0.0 | 0.0 | 0.0 | — |
Operating Income | 0.0 | 0.0 | 0.0 | — |
EBITDA | 0.0 | 0.0 | 0.0 | — |
Other Income / Expense | 0.0 | 0.0 | 0.0 | — |
Total Other Income / Expense | 0.0 | 0.0 | 0.0 | — |
Income Before Income Taxes | 0.0 | 0.0 | 0.0 | — |
Income Taxes | 0.0 | 0.0 | 0.0 | — |
Net Income | — | — | — | — |
Consolidated Net Income / Loss | 0.0 | 0.0 | 0.0 | — |
Net Income Attributable to Common Shareholders | 0.0 | 0.0 | 0.0 | — |
Basic EPS | $0.00 | $0.00 | $0.00 | — |
Diluted EPS | $0.00 | $0.00 | $0.00 | — |
Basic Shares Outstanding | 318.1M | 352.2M | 365.7M | — |
Diluted Shares Outstanding | 318.1M | 352.2M | 365.7M | — |